AUTL Stock, Autolus Therapeutics plc Information
Stock Information
Get AUTL Alerts
News, Short Squeeze, Breakout and More Instantly...
About Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.